亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台，协助业界发掘知识产权贸易商机，并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权，或是制造商需要购买技术以提高操作效能，又或是知识产权配套服务供应商，你将会从本网站发掘到有用的知识产权贸易资讯。

返回搜索结果

Novel Group A Streptococcal Vaccine and Therapeutics

详细技术说明

Scientists at UC San Diego have developed novel genetic GAS mutants expressing GAC without the GlcNAc side chain. This invention is the use of the A-variant carbohydrate purified from the mutant as a vaccine, which will induce anti-GAC antibodies that would be protective against all serotypes of GAS. The mutant GAC may also be used as a vaccine strategy against other medically important pathogens including groups C and G Streptococcus (GCS, GGS).

主要类别

生物医学

细分类别

病原

申请号码

20170196962

其他

Related Materials

van Sorge, N.M. et al. 2011. Streptococcus Pyogenes Group A Carbohydrate as Virulence Factor and Vaccine Candidate. Microbial Pathogenesis and Host Response Symposium, Cold Spring Harbor, New York.
Cole JN, Barnett TC, Nizet V, Walker MJ. Molecular Insight Into Invasive Group A Streptococcal Disease. Nat Rev Microbiol. 2011 Sep 16;9(10):724-36.

Tech ID/UC Case

22219/2012-011-0

Related Cases

2012-011-0

国家/地区

美国

欲了解更多信息，请点击这里